Dose of dialysis, convection and haemodialysis patients outcome--what the HEMO study doesn't tell us: the European viewpoint
Open Access
- 1 June 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 18 (6) , 1061-1065
Abstract
The main aims of dialysis treatment are to prolong patient survival, reduce morbidity and improve quality of life. However, despite many technical advances made over the last few years, morbidity and mortality of dialysis patients remain unacceptably high [1] and their quality of life is often poor.Keywords
This publication has 14 references indexed in Scilit:
- Effect of Dialysis Dose and Membrane Flux in Maintenance HemodialysisNew England Journal of Medicine, 2002
- Mortality Risk by Hemodialyzer Reuse Practice and Dialyzer Membrane Characteristics: Results From the USRDS Dialysis Morbidity and Mortality StudyAmerican Journal of Kidney Diseases, 2001
- A Comparison of On-Line Hemodiafiltration and High-Flux HemodialysisJournal of the American Society of Nephrology, 2000
- Lessons from the hemodialysis (HEMO) Study: An improved measure of the actual hemodialysis doseAmerican Journal of Kidney Diseases, 1999
- Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatmentsKidney International, 1999
- Effects of Hemodialyzer Reuse on Clearances of Urea and β2-MicroglobulinJournal of the American Society of Nephrology, 1999
- Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patientsKidney International, 1997
- Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parametersKidney International, 1996
- The dose of hemodialysis and patient mortalityKidney International, 1996
- A mechanistic analysis of the National Cooperative Dialysis Study (NCDS)Kidney International, 1985